China Raises The Bar On Generic TCM Quality
This article was originally published in PharmAsia News
Executive Summary
China recently revised the registration and approval regulation for generic traditional Chinese medicine (TCM), raising the quality bar for manufacturers and producers. It demands more specific details such as the TCM source, produce area and technology parameters, so as to ensure product standards and consistency. In addition, the regulation requires generic TCM to adhere closely to the original branded products in prescription composition, basic ingredients, production processes and technology parameters. Analysts note that the stricter regulations will encourage innovation and spur the development of the local industry. (Click here for more)